Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: A case series of nine patients and review of the literature

International Journal of Dermatology

Volumn 46, Issue 5, 2007, Pages 447-452

  Introcaso, Camille E ^a,b,c   Hivnor, Chad ^a,b,c   Cowper, Shawn ^a,b,c   Werth, Victoria P ^a,b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE; PSORALEN; STEROID; THALIDOMIDE;

CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIMB; NEPHROGENIC FIBROSING DERMOPATHY; PERITONEAL DIALYSIS; PHYSIOTHERAPY; PUVA; REVIEW; SKIN FIBROSIS; TRUNK; UNITED STATES; UNIVERSITY HOSPITAL;

FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; SKIN; SKIN DISEASES;

EID: 34248182038     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03301.x     Document Type: Review

References (32)

1. Cowper S, Robin H, Steinberg S, et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000-1001.
2. Goveia M. CDC public health dispatch: Fibrosing skin condition among patients with renal disease - United States and Europe, 1997-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 25-26.
3. Cowper S. Nephrogenic Fibrosing Dermopathy [NFD Website], 2001-4. URL http://www.icnfdr.org [accessed 8 November 2004].
4. Swartz R, Crofford L, Sem P, et al. Nephrogenic fibrosing dermopathy: A novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003; 114: 563-572.
5. Cowper S. Nephrogenic fibrosing dermopathy: The first 6 years. Curr Opin Rheumatol 2003; 15: 785-790.
6. Cowper S. Nephrogenic fibrosing dermopathy: Suspect identified, motive unclear. Am J Dermatopathol 2003; 3: 358.
7. Ting W, Stone S, Madison K, et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903-906.
8. Jimenez S, Artlett C, Sandorfi N, et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 2004; 50: 2660-2666.
9. Levine J, Taylor R, Elman L, et al. Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 2004; 30: 569-577.
10. Jan F, Segal J, Dyer J, et al. Nephrogenic fibrosing dermopathy: Two pediatric cases. Pediatrics 2003; 143: 678-681.
11. Jain M, Wesson S, Hassanein A, et al. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 2004; 19: 467-470.
12. Cowper S, Su L, Bhawan J, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393.
13. Hauser C, Kaya G, Chizzolini C. Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis. Dermatology 2004; 209: 50-52.
14. Evenepoel P, Zeegers M, Segaert S, et al. Nephrogenic fibrosing dermopathy: A novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 2004; 19: 469-473.
15. Gremmels J, Kirk G. Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease. Clin Nucl Med 2004; 29: 694-697.
16. Edsall L, English J, Teague M, et al. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 2004; 31: 247-253.
17. Taylor E, Henderson J, Rennke H, et al. Traumatic calcinosis cutis in a dialysis patient. Am J Kidney Dis 2004; 44: E18-e21.
18. Hershko K, Hull C, Ettefagh L, et al. A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: A syndrome of dysregulated matrix remodeling? J Cutan Pathol 2004; 31: 262-265.
19. Ruiz-Genao D, Pascual-Lopez M, Fraga S, et al. Osseous metaplasia in the setting of NFD. J Cutan Pathol 2005; 32: 172-175.
20. Streams B, Liu V, Liegeois N, et al. Clinical and pathologic features of nephrogenic fibrosing dermopathy: A report of two cases. J Am Acad Dermatol 2003; 48: 42-47.
21. Chesney J, Bucala R. Peripheral blood fibrocytes: Mesenchymal precursor cells and the pathogenesis of fibrosis. Curr Rheumatol Rep 2000; 2: 501-505.
22. Quan T, Cowper S, Wu S, et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36: 598-606.
23. Kafi R, Fisher G, Quan T, et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004; 140: 1322-1324.
24. Ortonne N, Lipsker D, Chantrel F, et al. Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: A new hypothesis. Br J Dermatol 2004; 150: 1050-1052.
25. Baron P, Cantos K, Hillebrand D, et al. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 2003; 25: 204-209.
26. Chiu H, Wells G, Carag H, et al. Nephrogenic fibrosing dermopathy: A rare entity in patients awaiting liver transplantation. Liver Transpl 2004; 10: 465-466.
27. Perazell M, Ishibe S, Perazella M, et al. Nephrogenic fibrosing dermopathy: An unusual skin condition associated with kidney disease. Semin Dial 2003; 16: 276-279.
28. Mackay-Wiggins J, Cohen D, Hardy M, et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003; 48: 55-60.
29. Lauchli S, Zortea-Caflisch C, Nestle F, et al. Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 2004; 208: 278-280.
30. Tan A, Tan S, Lian T, Ng S. A case of nephrogenic fibrosing dermopathy. Ann Acad Med Singapore 2004; 33: 527-529.
31. Chung H, Chung K. Nephrogenic fibrosing dermopathy: Response to high-dose intravenous immunoglobulin. Br J Dermatol 2004; 150: 596-597.
32. Hubbard V, Davenport A, Jarmulowicz M, et al. Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 2003; 148: 563-568.